Menu

Missy Broome

It's Missy!

Dr. David Samadi Has Created An Efficient Way Of Performing Prostate Surgery

Dr. David Samadi has always wanted To be a doctor who helps people as much as he can. It was when he discovered the amazing things that technology can do in the field of surgery that he became even more fascinated. Instead of performing prostate surgery the normal way, Dr. Samadi learned how to do it with robotics, and this skill has made him one of the top surgeons in his field.

Early on in his career, while working at a hospital, Dr. David Samadi felt disillusioned with the slow pace, but he eventually realized that he could work within the system to help patients as much as possible. During this time, and a lot of the rest of his career, he realized that he could work more efficiently, himself, by keeping up with a regular schedule. Part of this is getting up early, because he gets a lot done in the early morning time. Part of his regular daily habits also include encouraging others to do their best by recognizing the innate talents they already bring to the table.

Dr. David Samadi feels like one of his greatest accomplishments is the invention of the Samadi Modified Advanced Robotic Technique. His technique makes it so that he can offer surgery to his patients that has a lesser chance of causing nerve damage. He is glad that many of his patients got the surgery they needed due to what he has been able to create.

Dr. David Samadi diagnoses patients who have prostate cancer and works hard to offer them treatments that work. The robotic procedures that he has created have helped his patients to not have to deal with the possible side effects of surgery. Many people don’t know that he left his home country of Iran when he was younger after the Iranian Revolution. After this time, he lived in London and Belgium but eventually landed in the United States.

Dr. David Samadi received his biochemistry degree while studying at Stony Brook University, and completed his M.D. work while attending S.U.N.Y., Stony Brook School of Medicine in New York. By the year 2000, he had also studied urology at Albert Einstein College of Medicine and Montefiore Medical Center where he finished his postgraduate work. A year later he studied at the Memorial Sloan Kettering Cancer Center where he concluded a fellowship in oncology. One of his most memorable experiences took place with Professor Claude Abbou at the Henri Mondor Hospital Creteil in France where he finished a robotic radical prostatectomy fellowship.

Learn More: www.sharecare.com/doctor/dr-david-samadi-3

The Cancer Treatment Centers of America Drives Quality Cancer Care Through Strategic Collaborations

Cancer patients in the US are poised to benefit from a revolutionary collaboration between healthcare giants Allscripts and NantHealth with the Cancer Treatment Centers of America. The organization, which is headquartered in Boca Raton, Florida, operates a network of five national hospitals dedicated to fighting cancer. The facilities are in Georgia, Illinois, Oklahoma, Pennsylvania, and Arizona. The result is Clinical Pathways, an integrated treatment platform that enhances cancer therapy and physician’s clinical workflow.

The system provides physicians with a diverse range of evidence-based strategies that enable them to deliver safe and efficient therapy options to patients. It empowers the Cancer Treatment Centers of America, CTCA to provide personalized care to cancer patients that transforms their quality of life. In this case, it takes the guesswork out of the equation, provides a point of comparison between multiple therapy options and streamlines the treatment process.

The Allscripts medical system brings to the table a comprehensive medical database with thousands of treatment regimens. This is curated from peer-reviewed papers, oncology groups and state bodies. The treatment programs include supporting evidence, anticipated results, costs, risks and related literature.

CTCA offers innovative care strategies that improve the quality of life and minimize the risks associated with side effects. CTCA facilities have earned the reputation of being the best in the industry. Their inclusive approach ensures patients and their families are part of the therapy decisions. CTCA facilities have been recognized with numerous industry awards for delivering excellence in patient care.

Some of the honors come from the Centers for Medicare and Medicaid Services, American College of Radiology and the Association of Community Cancer Centers. The specialist hospital network was launched in 1988. It has a strong focus on quality patient-centered care driven by cutting-edge technology and collaborative initiatives. The multidisciplinary team of experts at CTCA is dedicated to providing informed precision therapies that improve the quality of life of cancer patients.

Visit More : http://www.myctca.com

Eric Lefkofsky and His Tempus Role

Eric Lefkofsky is the CEO and founder of Tempus. Under his auspices this technology company has built an operating system to battle cancer.This company through its research allows physicians to personalize the care of their cancer patient.

What Eric Lefkofsky has done is to found a company which is researching ways of treating cancer. Why did he do this? It stemmed from watching a family memberbeing treated for this terrible disease. His goal was to bring new and innovative technology to the doctors who are in the front lines treating these patients.

Tempus analyzes data so that physicians have real time data to treat their patients based on analytic s drawn from other cancer patients. They are trying to build precision oncology.

Tempus has built software that physicians can utilize and obtain information so they can treat their patients better without having to waste all of their time researching answers.

Tempus has created this software to make physicians work easier . This allows the doctor more time with the patient and less time comparing data that may be out there.

Tempus is not the only endeavor where Eric Lefkofsky is involved. He also wrote a book which he called “Accelerated Disruption.” This is explained as how a business “misses the boat “by not realizing that “technology can allow a challenge to come from anywhere.This is what the book states. This book was written by Eric Lefkofsky . In it he expresses that in order to compete and to emerge and grow in the coming years they have to improve their technology. Also he stressed that the right companies need to be chosen to be innovated to learn more: https://www.insidephilanthropy.com/guide-to-individual-donors/eric-lefkofsky.html click here.

Eric Lefkofsky is not only the CEO of Tempus but he is a trustee in many other organizations like the Lurie’s Children’s Hospital of Chicago,The Steppenwolf Theatre. Eric Lefkofsky”s philanthropic endeavors reach to wide domains, He even has started a foundation with his wife. It is called the Lefkofsky Family Foundation.

This foundation has under its umbrella many businesses and schools .Under Education the schools that are under this part of the umbrella ,each has a different thing that they bring to the table to enhance a child’ Another facet under this umbrella is human rights. It incorporates such companies as The Human Rights Watch and The Jewish United Fund . Both have human rights in their scope of practice.

The world is a better place for having Eric Lefkofsky in it because he uses his entrepreneurial skills to make a better world. And his later skills have proven to benefit mankind in the best possible way. He founded a company which is working diligently to help rid the world of cancer.

They are doing this by testing patient’s blood and arriving at the conclusion of what genotypes can make a person more prone to getting cancer in their lifetime and what type. Then they place this information on their software and send this information to physicians treating cancer in their patients. Eric Lefkofsky,entreprenuer extraordinaire.

Eric Lefkofsky’s Success with Tempus

An article, “This Is What’s Missing in the Data-Centric Approach to Cancer,” by Barb Darrow, on Fortune.com discusses the start-up, Tempus. Eric Lefkofsky, a co-founder, believes doctors and research communities need more information collected from past, current, and future cancer patients, in order give the patient better treatment. Mr Lefkofsky has made the connection, through his own wife’s battle with cancer, that clinical information on how a treatment has worked, from one patient to another, is not being shared effectively with researchers, doctors, and other people who may need to know.

Tempus is a company that takes the electronic medical records (EMR) of a patient, creates a clean version, without their personal information, and gives it back to the source. The doctor/hospital is then able to use the information to find patterns and ideas on how their treatments have worked on a variety of different people. Lefkofsky believes that by having patient’s results’ readily available for research, will individualize the possibility for a positive treatment on future patients.

Eric Lefkofsky likes to start new companies and sell them for profit. He has been extremely successful. He is currently co-founder, CEO of Tempus, co-founder, Chairman of Groupon, and co-founder of Uptake Technologies, Mediaocean, Echo, Global Logistics, and Inner Workings. Lefkofsky earned his undergraduate degree from the University of Michigan and his Juris Doctorate degree from the University ofMichigan Law School.

Lefkofsky, and his wife Liz, started the Lefkofsky Family Foundation, to contribute in areas, such as, education, science, and causes around the globe that will make the lives of people in their communities better. Lefkofsky also works with Lurie Children’s Hospital of Chicago, The Museum of Science and Industry and World Business Chicago, and The Art Institute of Chicago. Lefkofsky works as an adjunct professor at the University of Chicago, and he has written a book, “Accelerated Disruption”.

http://chicagoinno.streetwise.co/2016/07/22/eric-lefkofskys-next-move-curing-cancer-at-tempus/